Literature DB >> 6737076

Scintigraphy of a neuroblastoma with I-131 meta-iodobenzylguanidine.

B Kimmig, W E Brandeis, M Eisenhut, B Bubeck, H J Hermann, K zum Winkel.   

Abstract

Radioiodinated m-iodobenzylguanidine has been applied mainly for the diagnosis of pheochromocytoma and blastoma. In this paper we show that an ontogenetically related tumor, the neuroblastoma, is also scintigraphically visualized by its high uptake of I-131 MIBG. Because of the kinetic findings and the high uptake of more than 30% of the injected activity, it is likely that the neuroblastoma, by analogy with pheochromocytoma, is susceptible to specific radionuclide therapy.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6737076

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  19 in total

Review 1.  Radiopharmaceutical diagnosis and therapy of sympatho-medullary disorders.

Authors:  B Shapiro
Journal:  Ann Nucl Med       Date:  1996-02       Impact factor: 2.668

Review 2.  Targeted radiotherapy for neuroblastoma.

Authors:  S Meller
Journal:  Arch Dis Child       Date:  1997-11       Impact factor: 3.791

3.  VMA-negative, MIBG scan-positive neuroblastoma in children.

Authors:  A Miceli; L Nespoli; C Aprils; G R Burgio
Journal:  Eur J Pediatr       Date:  1986-09       Impact factor: 3.183

4.  Dosimetry for 131I-MIBG therapies in metastatic neuroblastoma, phaeochromocytoma and paraganglioma.

Authors:  Ferdinand Sudbrock; Matthias Schmidt; Thorsten Simon; Wolfgang Eschner; Frank Berthold; Harald Schicha
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-02-24       Impact factor: 9.236

5.  Iodine-131 metaiodobenzylguanidine scintigraphy for localization of lesions in children with neuroblastoma: comparison with computed tomography and ultrasonography.

Authors:  S Lastoria; S Maurea; C Caracò; E Vergara; L Maurelli; P Indolfi; F Casale; M T di Tullio; M Salvatore
Journal:  Eur J Nucl Med       Date:  1993-12

6.  Radionuclide therapy of malignant pheochromocytoma with 131I-MIBG.

Authors:  Y Nakabeppu; M Nakajo
Journal:  Ann Nucl Med       Date:  1994-11       Impact factor: 2.668

7.  The diagnostic and therapeutic utility of radioiodinated metaiodobenzylguanidine (MIBG). 5 years of experience.

Authors:  L Troncone; V Rufini; P Montemaggi; F M Danza; A Lasorella; R Mastrangelo
Journal:  Eur J Nucl Med       Date:  1990

8.  Consolidating the role of *I-MIBG-scintigraphy in childhood neuroblastoma: five years of clinical experience.

Authors:  A Jacobs; M Delree; B Desprechins; J Otten; A Ferster; M H Jonckheer; J Mertens; H R Ham; A Piepsz
Journal:  Pediatr Radiol       Date:  1990

9.  131I-meta-iodobenzylguanidine scintigraphy in patients with neuroblastoma.

Authors:  S Hibi; S Todo; S Imashuku; T Miyazaki
Journal:  Pediatr Radiol       Date:  1987

10.  Value of MRI and MIBG-I123 scintigraphy in the diagnosis of spinal bone marrow involvement in neuroblastoma in children.

Authors:  B Bourliere Najean; S Siles; M Panuel; S Cammilleri; F Faure; P Devred; G Kaphan
Journal:  Pediatr Radiol       Date:  1992
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.